Cutler Group LP Pliant Therapeutics, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$12.85 - $19.15 $1,285 - $1,914	-100 Reduced 10.0%	900 $16,000
Q2 2023 Jul 18, 2023	SELL	$18.12 - $30.56 $40,353 - $68,057	-2,227 Reduced 69.01%	1,000 $18,000
Q1 2023 May 01, 2023	BUY	$18.73 - $36.26 $21,108 - $40,865	1,127 Added 53.67%	3,227 $85,000
Q4 2022 Feb 07, 2023	BUY	$17.0 - $25.43 $30,600 - $45,774	1,800 Added 600.0%	2,100 $40,000
Q3 2022 Oct 25, 2022	SELL	$7.67 - $24.23 $4,602 - $14,538	-600 Reduced 66.67%	300 $6,000
Q2 2022 Aug 04, 2022	BUY	$4.11 - $8.75 $3,699 - $7,875	900 New	900 $7,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.